📰 Thomas Sandgaard News
Thomas Sandgaard News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Thomas Sandgaard. Real-time updates on events, politics, business and more.
February 29, 2024
Despite Revenue Uplift, Net Income and Adjusted EBITDA Experience Downturn
January 21, 2024
Blues left-back Matt Penney has joined fellow League One side Charlton Athletic on loan for rest of the season.
November 16, 2023
ENGLEWOOD - Zynex, Inc. , an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient...
November 15, 2023
/PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...
November 1, 2023
Zynex Inc's (NASDAQ: ZYXI) board of directors approved a program to repurchase up to $20.0 million.  The program will commence on November 1, 2023, and is scheduled to terminate earlier than November 1, 2024, or when the $20.0 million limit is reached. 
October 27, 2023
Zynex, Inc. (NASDAQ:ZYXI) Q3 2023 Earnings Call Transcript October 26, 2023 Zynex, Inc. beats earnings expectations. Reported EPS is $0.1, expectations were $0.09. Operator: Good day ladies and gentlemen, and welcome to the Zynex Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] A question-and-answer session […]
October 26, 2023
Zynex Inc Founder and CEO Thomas Sandgaard joined Steve Darling from Proactive to share news the company has been recognized as one of the Top 100 Healthcare Technology Companies of 2023 by The...
October 24, 2023
Zynex Inc Founder and CEO Thomas Sandgaard joined Steve Darling from Proactive to share news the company has been recognized as one of the Top 100...
October 19, 2023
/PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...
October 12, 2023
Key Insights Significant insider control over Zynex implies vested interests in company growth The top 3 shareholders...